We use cookies to make your experience better. To comply with the new e-Privacy directive, we need to ask for your consent to set the cookies. Learn more.
Disease Modeling
From 2D to Organ-on-a-Chip: Platforms Powering Modern Disease Models
Over the past decade, disease models have advanced rapidly, providing new ways to study human biology with greater accuracy and relevance. While animal models once Read more...Modeling Neurodegenerative Disorders: Where Are We Now?
Neurodegenerative diseases are chronic and progressive medical conditions that lead to neuronal degeneration and neuronal cell loss.1 Their pathophysiology is Read more...Moving Beyond Animal Models with iPSC-based Models: Shifts and New Challenges
For decades, animal models have served as the foundation of biomedical research and drug development. However, growing ethical concerns, high costs, and limited Read more...Patient-derived Organoids for Cell Therapy Development: The Needs Behind the Innovation
Advances in human-relevant disease models have reshaped early-stage drug discovery, but the development of cell therapies demands even more sophisticated platforms Read more...
Recent Posts
- From 2D to Organ-on-a-Chip: Platforms Powering Modern Disease Models
- Modeling Neurodegenerative Disorders: Where Are We Now?
- Moving Beyond Animal Models with iPSC-based Models: Shifts and New Challenges
- Patient-derived Organoids for Cell Therapy Development: The Needs Behind the Innovation
-
How Monoclonal Antibodies Have Transformed Breast Cancer Treatment, and Where is it Going Next
